DERMAQUEST – Advanced C Infusion Moisturizing Serum
R2295,00
Size: 30ml
Advanced C Infusion Serum boasts an acid free exfoliation complex to gently shed dead skin cells without causing irritation. it brightens and improves the structure of your skin by increasing firmness as it promotes and protects collagen and elastin proteins.
C Infusion Serum uses orange plant stem cells, known to fortify and support skin structure while the potent, oil soluble vitamin c (bv-osc) which boosts collagen production by 50%, improves the appearance of hyperpigmentation and protects against environmental damage. C Infusion Serum energizes skin as it diminishes the visible signs of environmental aging.
Best for: C Infusion Serum is appropriate for most skin types (not recommended for acne prone)- especially those experiencing drier, dull, environmentally damaged skin. This serum is ideal for anyone looking to combat signs of aging, uneven skin tone and texture while revitalizing damaged, dull skin with fine lines and wrinkles.
How to use:
- Apply one pump of serum to clean skin, wait a few moments for maximum penetration and effect prior to applying additional products.
Key Ingredients:
- THD Ascorbate
- Polypeptide Blend
- Citrus Stem Cells
Benefits:
- Provides moisture and hydration while mattifying excess oil.
- Helps balance skin without causing sebum rebound.
- Soothes and calms redness and discomfort typically associated with breakouts.
Frequently purchased with:
- DermaQuest C-Infusion Cleanser
- DermaQuest MelaQuest Serum with Cysteamine
- DermaQuest MelaQuest Cream
Pay over 3 EQUAL zero-interest instalments of R765,00 with PayJustNow.
Or pay over 12 instalments of with PayJustNow.
Find out how...
Your flexible payment provider.
Example payment for
x 3
0% interest, zero fees.
0% interest, zero fees.
Pay in 3
x 12
28% interest, plus fees.
Total Payment
28% interest, plus fees.
Total Payment
Pay in 12
How does PayJustNow work?
You can complete sign-up in under 2 minutes - no need to leave your cart!
Out of stock
There are no reviews yet.